Proton pump inhibitor

From Citizendium
Revision as of 10:13, 14 August 2009 by imported>Robert Badgett (→‎Metabolism)
Jump to navigation Jump to search
This article is a stub and thus not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, proton pump inhibitors (PPI) are medications that "inhibit H(+)-K(+)-exchanging atpase. They are used as anti-ulcer agents and sometimes in place of histamine H2 antagonists for gastroesophageal reflux."[1] They are also used as part of curative [therapy for Helicobacter pylori, in combination with antibiotics.

Metabolism

Proton pump inhibitors are metabolized by the CYP2C19 isoenzyme of cytochrome P-450. This may be less true for pantoprazole and esomeprazole.[2]

Adverse effects

Proton pump inhibitors may be associated with spontaneous bacterial peritonitis.[3] These drugs may also be associated with pneumonia, Clostridium difficile diarrhea, and fractures.

Proton pump inhibitors, which are metabolized by the CYP2C19 isoenzyme of cytochrome P-450, may[4] or may not[5] increase adverse cardiac events when given to patients taking clopidogrel for coronary heart disease.

References